Insider · CIK 0001478244

Currie Mark G

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001478244

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+63.5K sh	—	—	676,900
2025-06-10	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+45K sh	—	—	613,419
2024-06-18	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+24.3K sh	—	—	568,419
2023-06-20	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+22.4K sh	—	—	544,108
2022-08-11	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−70K sh	$11.78	−$825K	521,758
2022-06-07	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−190K sh	—	—	0
2022-06-07	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+190K sh	$11.65	+$2.22M	782,141
2022-06-07	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−190K sh	$12.01	−$2.29M	591,758
2022-06-01	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+21.6K sh	—	—	591,758
2021-06-14	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−23.6K sh	$11.59	−$273K	570,187
2021-06-02	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+22.8K sh	—	—	593,758
2020-12-28	KRSAKorsana Biosciences, Inc.S Sale	President and CSO	SSale	−20.1K sh	$3.01	−$60.5K	251,648
2020-06-03	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+21.7K sh	—	—	570,992
2020-01-23	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$9.12	+$547K	609,272
2020-01-23	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−60K sh	$12.59	−$755K	549,272
2020-01-23	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	47,707
2020-01-16	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−8,888 sh	$12.80	−$114K	549,272
2020-01-16	IRWDIRONWOOD PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,888 sh	$10.02	+$89.1K	558,160
2020-01-16	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,888 sh	—	—	0
2019-12-30	KRSAKorsana Biosciences, Inc.S Sale	President and CSO	SSale	−25K sh	$2.48	−$62K	271,755
2019-12-27	KRSAKorsana Biosciences, Inc.S Sale	President and CSO	SSale	−25K sh	$2.55	−$63.7K	296,755
2019-12-17	IRWDIRONWOOD PHARMACEUTICALS INCG Gift	Director	GGift	−500 sh	—	—	549,272
2019-12-16	IRWDIRONWOOD PHARMACEUTICALS INCG Gift	Director	GGift	−1,837 sh	—	—	549,772
2019-11-22	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+75K sh	—	—	75,000
2019-05-29	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+22.7K sh	—	—	551,609
2019-05-10	IRWDIRONWOOD PHARMACEUTICALS INCS Sale	Director	SSale	−4,055 sh	$10.53	−$42.7K	528,903
2019-04-02	KRSAKorsana Biosciences, Inc.P Purchase	President and CSO	PPurchase	+270K sh	$14.81	+$4M	321,755
2019-04-01	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+2,995 sh	—	—	532,958
2019-04-01	IRWDIRONWOOD PHARMACEUTICALS INCA Award	Director	AAward	+1,483 sh	—	—	529,963
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+515K sh	—	—	514,698
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+141K sh	—	—	140,984
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+113K sh	—	—	113,413
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+2,500 sh	—	—	2,500
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+9,930 sh	—	—	9,930
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+50.8K sh	—	—	50,794
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+2,500 sh	—	—	2,500
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+50.8K sh	—	—	50,801
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+27.8K sh	—	—	27,772
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+888 sh	—	—	888
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+17.5K sh	—	—	17,490
2019-04-01	KRSAKorsana Biosciences, Inc.A Award	President and CSO	AAward	+51.6K sh	—	—	51,648
2019-04-01	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−563K sh	—	—	37,500
2019-04-01	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−148K sh	—	—	67,187
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+37.3K sh	—	—	37,286
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+17.5K sh	—	—	17,491
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+27.8K sh	—	—	27,773
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+37.3K sh	—	—	37,279
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+13.1K sh	—	—	13,125
2019-04-01	KRSAKorsana Biosciences, Inc. · Employee Stock Option (Right to Buy)A Award	President and CSO	AAward	+113K sh	—	—	113,430
2019-04-01	IRWDIRONWOOD PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−109K sh	—	—	140,625

Recent filings

Accepted (ET)
Jun 174
Currie Mark G0001193125-26-274288
SEC(opens sec.gov)
Jun 124
Currie Mark G0000950170-25-085440
SEC(opens sec.gov)
Jun 214
Currie Mark G0000950170-24-076206
SEC(opens sec.gov)
Jun 224
Currie Mark G0001209191-23-039132
SEC(opens sec.gov)
Aug 154
Currie Mark G0001209191-22-045808
SEC(opens sec.gov)
Jun 94
Currie Mark G0001209191-22-035443
SEC(opens sec.gov)
Jun 34
Currie Mark G0001209191-22-033983
SEC(opens sec.gov)
Jun 164
Currie Mark G0001209191-21-040892
SEC(opens sec.gov)
Jun 44
Currie Mark G0001209191-21-038179
SEC(opens sec.gov)
Dec 304
Currie Mark G0001140361-20-029869
SEC(opens sec.gov)
Jun 54
Currie Mark G0001209191-20-034692
SEC(opens sec.gov)
Jan 244
Currie Mark G0001209191-20-004855
SEC(opens sec.gov)
Jan 214
Currie Mark G0001209191-20-004301
SEC(opens sec.gov)
Dec 314
Currie Mark G0001209191-19-062322
SEC(opens sec.gov)

Companies

Address

C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300

BOSTON, MA, 02110